Cadrenal Therapeutics, Inc. (CVKD) — research page
US · us-cm-kg/NASDAQ/CVKD · as of 2026-11-08
Identity and listing
Cadrenal Therapeutics, Inc. is listed on NASDAQ under the ticker CVKD, ISIN US1276362076. The LEI is not on the record. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The segment is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Cadrenal Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CVKD | source · 2026-11-08 |
| ISIN | US1276362076 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 76 filings across 50 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 4 days. The latest filing is dated 2026-10-13 and is a directors' dealings filing, 26 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 76 | 4 | 26 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-13 | directors_dealings | 4 | 4 — OWNERSHIP DOCUMENT |
| 2026-10-13 | directors_dealings | 4 | 4 — OWNERSHIP DOCUMENT |
| 2026-10-13 | directors_dealings | 4 | 4 — OWNERSHIP DOCUMENT |
| 2026-10-13 | directors_dealings | 4 | 4 — OWNERSHIP DOCUMENT |
| 2026-10-13 | directors_dealings | 4 | 4 — OWNERSHIP DOCUMENT |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is WithumSmith+Brown, PC, of East Brunswick, New Jersey. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record. The segment move is not on the record. The issuer is not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
Two research houses are named on the issuer's investor-relations page: H.C. Wainwright & Co. and Noble Capital Markets.
| research house | analyst | source · read date |
|---|---|---|
| H.C. Wainwright & Co. | Joseph Pantginis, Ph.D. | issuer page · 2026-11-11 |
| Noble Capital Markets | Robert LeBoyer | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The sealed years that hold the issuer are 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001937993.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/CVKD (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1937993/000121390026036946/ea0283741-10k_cadrenal.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://www.cadrenal.com/analyst-coverage/ (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/CVKD (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US1276362076"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:62bfd3c86d2745a3.